IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025

About this update from In8bio, Inc.

[{"type":"image","alt":"IN8bio, Inc","displaySize":"","headline":null,"caption":"IN8bio, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":149,"url":"https://media.zenfs.com/en/globenewswire.com/2eaff8c6754066d4f7498c1179b53d18"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LM3P9KMIYObIbb2x2kkziw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIwOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2eaff8c6754066d4f7498c1179b53d18","width":300,"height":149}},"lazy":false},{"type":"text","content":"NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that the Company will participate in multiple sessions at the Immuno-Oncology 360° (IO360°) Conference 2025, held March 24-26, 2025, in Boston, MA.","length":367,"tagName":"p"},{"type":"text","content":"William Ho, Chief Executive Officer and co-founder of IN8bio, will be Co-Chairing Day 2 of the conference starting at 8:15 AM EDT on March 25, 2025. He will deliver the welcoming remarks and discuss, “Tackling the Tough Questions in IO for Autoimmunity Disease.” After, he will Chair the session, “State of the IO Market, Investments and Deals Plenary.”","length":353,"tagName":"p"},{"type":"text","content":"During the afternoon session, at 4:35 PM EDT, Mr. Ho will present on the topic of “Picking our Horse in the Race for Autoimmunity: The Gamma-Delta T cell Engager,” and provide a corporate overview of IN8bio’s recently announced INB-619, T cell engager program for oncology and autoimmune diseases.","length":297,"tagName":"p"},{"type":"text","content":"As co-chair and panelist, Mr. Ho expects to discuss the rationale and promise of a gamma-delta T cell engager in addressing autoimmunity, a rapidly emerging frontier for immunotherapies.","length":186,"tagName":"p"},{"type":"text","content":"Presentation and Panel Details","length":30,"tagName":"p"},{"type":"text","content":"Co-Chairs' Welcome & Tackling the Tough Questions in IO for Autoimmunity Disease","length":88,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date/Time: March 25, 2025, at 8:15 AM EDT","length":41,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":41,"olType":false},{"type":"text","content":"Picking...

More updates from In8bio, Inc.